Mitsubishi Electric Corporation

Ngk Insulators, Inc.

Hisamitsu Pharmaceutical Company, Inc.

Chiba-prefecture

Takahiro Hirata

Hiroyuki Kubo

Makoto Tanikawa

Takeshi Goto

Akira Nakagawara

Yasuko Yoshida

Tomomi Higashikawa

Akiyoshi Muramatsu

Shin Ishii

Saichi Yamada

Miki Ohira

An inverter control device that controls an inverter unit that converts a DC voltage from a converter unit to an AC voltage and supplies the AC voltage to the DC motor includes a storage unit that stores therein information regarding a synchronization-loss limit; a synchronization-loss limit-current calculation unit that calculates the limitation value on the synchronization-loss limit current on the basis of the magnet temperature of the DC motor, the bus voltage to be applied to the inverter unit, and the information regarding a synchronization-loss limit; and a control unit that compares the primary current to be input to the converter unit with the limitation value and that, when the primary current exceeds the limitation value, outputs an adjustment command to adjust the operating frequency of the DC motor such that the primary current becomes equal to or less than the limitation value.

Inverter control device and air conditioner

A microarray for predicting the prognosis of neuroblastoma, wherein the microarray has 25 to 45 probes related to good prognosis, which are hybridized to a gene transcript whose expression is increased in a good prognosis patient with neuroblastoma and are selected from 96 polynucleotides consisting of the nucleotide sequences of SEQ. ID NOs. 1, 5, 6, 14. 16, 17, 19, 22-24, 28, 29, 31, 37, 39, 40, 43, 44, 47-52, 54, 57-60, 62, 64, 65, 67, 68, 72-75, 77, 78, 80-82, 84, 87, 89-91, 94, 100, 103, 112, 113, 118, 120, 129, 130, 132, 136, 138, 142, 144, 145, 148, 150-153, 155, 158-160, 163-165, 169-171, 173, 174, 177, 178, 180-182, 184, 186, 187, 189, 191, 192, 194, 195, 198-200 or their partial continuous sequences or their complementary strands, and 25 to 45 probes related to poor prognosis, which are hybridized to a gene transcript whose expression is increased in a poor prognosis patient with neuroblastoma and are selected from 104 polynucleotides consisting of the nucleotide sequences of SEQ. ID NOs. 2-4, 7-13, 15, 18, 20, 21, 25-27, 30, 32-36, 38, 41, 42, 45, 46, 53, 55, 56, 61, 63, 66, 69-71, 76, 79, 83, 85, 86, 88, 92, 93, 95-99, 101, 102, 104-111, 114-117, 119, 121-128, 131, 133-135, 137, 139-141, 143, 146, 147, 149, 154, 156, 157, 161, 162, 166-168, 172, 175, 176, 179, 183, 185, 188, 190, 193, 196, 197 or their partial continuous sequences or their complementary strands.

Microarray for predicting the prognosis of neuroblastoma and method for predicting the prognosis of neuroblastoma

Growing community of inventors

Tokyo, Japan

Takahiro Hirata